-=6 HEADLINES

Indian Market

Indian equity markets were up 0.38%

Nifty up by 23.15 pts and settle at 6169.90

Sensex up by 34.37 pts at 20247.33

Bank Nifty up by 161.60 pts at 13239.50

Global Market

European markets were up with FTSE up by 8.99 closed at 6702 ,CAC down by 10.34 closed at 3971 and DAX down 9.82 closed at 8352

Dow future was up by 1 closed at

15236.00

WWW.EPICRESEARCH.CO 09752199966

DAILY EQUITY NEWSLETTER

17TH MAY 2013

HEADLINES

• AirAsia's Chandilya will have to be cost

leader in India

• RBI to kickstart sale of inflation-indexed

bonds on June 4

• Adani Ports Q4 net profit triples to Rs

710.31 cr

• CARE's Q4 revenue at Rs 63 crore, net

at Rs 36 crore

FII’s and DII’s

CATEGORY DATE BUY SELL NET

FII 15-May-13 4362.4 2715.45 1646.95

DII 15-May-13 1244.05 1991.16 -747.11

NIFTY DAILY PIVOTS

PIVOT R4 R3 R2 R1 PP S1 S2 S3 S4

NIFTY 6338 6279 6220 6194 6161 6135 6102 6043 5984

WWW.EPICRESEARCH.CO 09752199966

MARKET ANALYSIS:

Key benchmark indices nudged higher as index heavyweight Reliance Industries (RIL) gained. The

barometer index, the S&P BSE Sensex, was provisionally up 34.31 points or 0.7%, off close to 80

points from the day's high and up about 85 points from the day's low. The market breadth, indicating

the overall health of the market, was negative.

Index heavyweight and cigarette major ITC dropped ahead of its Q4 results tomorrow, 17 May 2013.

Auto stocks fell. Bajaj Auto declined on reporting weak Q4 results. Pharma stocks rose on renewed

buying, with Lupin hitting record high and Glenmark Pharmaceuticals hitting 52-week high. Reliance

Capital turned volatile after reporting weak Q4 results.

Indian stocks gained for the third straight day today, 16 May 2013.Foreign institutional investors (FIIs)

bought shares worth a net Rs 1646.95 crore on Wednesday, 15 May 2013, as per provisional data from

the stock exchanges.

As per provisional figures, the S&P BSE Sensex was up 34.31 points or 0.7% to 20,247.27. The index

rose 113.52 points at the day's high of 20,326.48 in morning trade, its highest level since 6 January

2011. The index fell 50.84 points at the day's low of 20,162.12 in opening trade. Pharma stocks rose on

renewed buying. Cipla, Dr Reddy's Laboratories, and Ranbaxy Laboratories rose by 2.3% to 3.04%.

Sun Pharmaceutical Industries fell 0.39%.Lupin rose 3.08% to Rs 806.60. The stock hit record high of

Rs 810.80 in intraday trade today, 16 May 2013.

STOCKS TO WATCH

BAJAJ AUTO

CAIRN INDIA

TCS

INFOSYS

SCRIPS IN BAN PERIOD

WWW.EPICRESEARCH.CO 09752199966

.

EXPERT OPINION

NIFTY

Nifty looks Bearish

Strategy: Sell on rise

Support: 6100

Resistance: 6200

BANK NIFTY

Bank Nifty looks Bearish

Strategy: Sell on rise

Support: 13000

Resistance: 13150

460

.0

GAINERS AND LOOSERS

PREVIOUS PERFORMANCE

TYPE SCRIP B/S RESULT

CASH RELIANCE

COMMUNICATION B TGT HIT

CASH VOLTAS B TGT HIT

FUTURE APOLLO TYRE B TGT HIT

FUTURE ADANI POWER S NOT

EXECUTED

DAILY NIFTY GAINERS

SCRIPS RATE VOL.

(000)

PR.

CLOSE

NET

CHAN

GE

%

CHANG

E

JP Associate

80.05 32873.81 75.80 4.25 5.61

IDFC 163.35 9529.19 158.05 5.30 3.35

Lupin 806.90 1775.87 782.00 24.90 3.18

Cipla 422.10 2601.21 411.10 11.00 2.68

Reliance Indus

840.65 3473.90 819.00 21.65 2.64

DAILY NIFTY LOOSERS

SCRIPS RATE VOL.

(000)

PR.

CLOSE

NET

CHAN

GE

%

CHAN

GE

NMDC 124.55 2382.96 128.35 -3.80 -2.96

Tata Motors

303.65 5186.19 308.85 -5.20 -1.68

ITC 337.00 7384.78 342.45 -5.45 -1.59

Jindal Steel & Power

308.35 2629.50 312.70 -4.35 -1.39

TCS 1454.05 1207.83 1471.55 -17.50 -1.19

6

.

MARKET CALLS

CASH

SCRIPS ACTION LEVEL 1ST

TARGET 2ND

TARGET STOP LOSS

ALLAHBAD BANK BUY 127.00 128.00 129.00 126.00

SESA GOA BUY 168.50 169.50 170.50 167.50

FUTURE

SCRIPS ACTION LEVEL 1ST

TARGET 2ND

TARGET STOP LOSS

APOLLO TYRE BUY 92.60 93.10 93.60 92.10

CROMPTON GREAVES

BUY 97.40 97.90 98.40 96.90

Disclaimer

The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.

Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable.

This material is for personal information and based upon it & takes no responsibility

The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE.

The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer.

All Rights Reserved. Investment in equity & bullion market has its own risks.

We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.